Safety and Immunogenicity of Revaccination With Influenza Vaccine in Ambulatory Elderly Subjects Previously Vaccinated With Fluzone ID, Fluzone HD, and Fluzone IM.
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi
- 12 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 08 Nov 2008 New trial record.